Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis

Clinical and Experimental Allergy

Volumn 34, Issue 6, 2004, Pages 952-957

  Bernstein, D I ^a   Levy, A L ^b   Hampel, F C ^c   Baidoo, C A ^d   Cook, C K ^e   Philpot, E E ^e   Rickard, K A ^e  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Spartanburg Pharmaceutical Research ^*  (United States)

^c Central Texas Health Research   (United States)

^d GLAXOSMITHKLINE   (Canada)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Allergic rhinitis; Corticosteroids; Eye; Fluticasone propionate; Intranasal administration; Loratadine; Ocular

Indexed keywords

ALLERGEN; CORTICOSTEROID; FLUTICASONE PROPIONATE; LORATADINE; PLACEBO;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EYE COLOR; EYE DISEASE; FEMALE; HUMAN; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OCULAR PRURITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEASONAL VARIATION; SKIN TEST; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AEROSOLS; ANDROSTADIENES; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SAMPLE SIZE;

EID: 3042582150     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01952.x     Document Type: Article

References (38)

1. Dykewicz MS, Fineman S. Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. Ann Allergy Asthma Immunol 1998; 81 (Part II):478-518.
2. Allergic rhinitis: clinical development programs for drug products. Food and Drug Administration draft guidance for industry April 2000.
3. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988; 88:869-77.
4. Calderon-Zapata MA, Davies RJ. Treatment and management of allergic rhinitis. In: Kay AB, editor. Allergy and allergic diseases. Oxford: Blackwell, 1997, p. 1327-43.
5. Settipane G, Korenblat PE, Winder J et al. Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther 1995; 17:252-63.
6. Dolovich J, Wong AG, Chodirker WB et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 1994; 73:147-53.
7. Scadding GK, Lund VJ, Holmstrom M, Darby YC. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial allergic rhinitis. Rhinology 1991; 11 (Suppl.):37-43.
8. Tinkelman D, Falliers C, Gross G et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann Allergy 1990; 64:234-40.
9. Bjerrum P, Illum P. Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate. Allergy 1985; 40:65-59.
10. Bernstein DI, Creticos PS, Busse WW et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97:749-55.
11. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989; 83:627-33.
12. Brooks CD, Francom SF, Peel BG, Chene BL, Klott KA. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination. Am J Rhinol 1996; 10:193-9.
13. Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray vs. loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol 2000; 84:533-8.
14. Gawchik SM, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis. Am J Manag Care 1997; 3:1052-8.
15. 1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. Brit Med J 1998; 317:1624-9.
16. Stempel DA, Thomas M. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids vs. nonsedating antihistamines. Am J Manag Care 1998; 4:89-96.
17. Frolund L. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 1991; 16:527-31.
18. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84 (Suppl. A):25-9.
19. Howland WC 3rd. Fluticasone propionate: topical or systemic effects? Clin Exp Allergy 1996; 26 (Suppl. 3): 18-22.
20. Ratner PH, van Bavel JH, Martin BG et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998; 47:118-25.
21. LaForce CF, Dockhorn RJ, Findlay SR et al. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract 1994; 38:145-52.
22. Nathan RA, Bronsky EA, Fireman P et al. A once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991; 67:332-8.
23. Banov CH, Woechler TR, LaForce CF et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994; 73:240-6.
24. DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 2003; 24:331-7.
25. Linder A. Symptom scores as measurements of the severity of rhinitis. Clin Allergy 1988; 18:29-37.
26. Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann Allergy 1994; 72:354-9.
27. Meltzer EO, Rickard KA, Westlund RE, Cook CK. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray. Ann Allergy Asthma Immunol 2001; 86:286-91.
28. Day JH, Buckeridge DL, Clark RH, Briscoe MP, Phillips R. A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996; 97:1050-7.
29. Bronsky EA, Dockhorn RJ, Meltzer EO et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:915-21.
30. vanBavel J, Findlay SR, Hampel FC, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994; 154:2699-704.
31. Undem BJ, Kajekar R, Hunter DD et al. Neural integration and allergic disease. J Allergy Clin Immunol 2000; 106:S213-20.
32. Baraniuk JN, Silver PB, Kaliner MA et al. Perennial rhinitis subjects have altered vascular, glandular, and neural responses to bradykinin nasal provocation. Int Arch Allergy Immunol 1994; 103:202-8.
33. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in symptomatic allergic individuals is mediated by neural reflexes. J Allergy Clin Immunol 1996; 97:1252-63.
34. Daley-Yates PT, Baker RC. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations. Br J Clin Pharmacol 2001; 51:103-5.
35. Banov CH, Woechler TR, LaForce CF et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994; 73:240-6.
36. van As A, Bronsky EA, Dockhorn RJ et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 1993; 91:1146-54.
37. Lindqvist N, Andersson M, Bende M, Loth S, Pipkorn U. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989; 19:71-6.
38. Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 2000; 105:912-6.